BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31085779)

  • 1. Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations.
    Allen LV
    Int J Pharm Compd; 2019; 23(2):135-143. PubMed ID: 31085779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(4):344-53. PubMed ID: 23969772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL; ;
    J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA.
    Kiseļova O; Mauriņa B; Šidlovska V
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations.
    Allen LV
    Int J Pharm Compd; 2021; 25(6):491-496. PubMed ID: 34807845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases.
    Vanhoorne V; Peeters E; Van Tongelen I; Boussery K; Wynendaele E; De Spiegeleer B; Remon JP; Vervaet C
    Orphanet J Rare Dis; 2019 Aug; 14(1):186. PubMed ID: 31370862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basics of Compounding with Dilutions and Concentrates.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):39-45. PubMed ID: 28346197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating.
    Martin M
    Int J Pharm Compd; 2018; 22(4):303-312. PubMed ID: 30021186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Extemporaneously Compounded Nasal Preparations Prescribed by Latvian Otorhinolaryngologists and General Practitioners and Comparison with German Formulations.
    Kiselova O; Maurina B; Sidlovska V
    Int J Pharm Compd; 2020; 24(6):491-500. PubMed ID: 33217739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved.
    Allen LV
    Int J Pharm Compd; 2021; 25(5):396-400. PubMed ID: 34623966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules.
    Dijkers E; Nanhekhan V; Thorissen A; Polonini H
    Int J Pharm Compd; 2017; 21(2):171-175. PubMed ID: 28346214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basics of Sterile Compounding: Vehicles Used in Sterile Compounding.
    Allen LV
    Int J Pharm Compd; 2019; 23(3):221-228. PubMed ID: 31085791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Probiotic Ingredient Safety Supporting Monograph Development Conducted by the United States Pharmacopeia (USP).
    Boyte ME; Akhtar N; Koshy B; Roe AL
    J Diet Suppl; 2024 Feb; ():1-39. PubMed ID: 38356247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(4):313-23. PubMed ID: 23974791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality specifications for articles of botanical origin from the United States Pharmacopeia.
    Ma C; Oketch-Rabah H; Kim NC; Monagas M; Bzhelyansky A; Sarma N; Giancaspro G
    Phytomedicine; 2018 Jun; 45():105-119. PubMed ID: 29778318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(6):492-9. PubMed ID: 23994811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basics of compounding: application of the United States pharmacopeia bacterial endotoxins test to compounded sterile preparations.
    Dawson MF
    Int J Pharm Compd; 2006; 10():36-9. PubMed ID: 23974125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection.
    Allen LV
    Int J Pharm Compd; 2022; 26(3):219-228. PubMed ID: 35657746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic of compounding: Repackaging, Part 1.
    Allen LV
    Int J Pharm Compd; 2013; 17(1):54-60. PubMed ID: 23627248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.